TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
IOSP

Innospec Inc

Basic Materials · Specialty Chemicals

93.20$ +0.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Innospec Inc (IOSP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 1,778 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement IOSP
Line item 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
465 517 422 421 452 462 481 528 532 602 641 599 683 774 776 819 961 1,012 883 1,307 1,477 1,513 1,193 1,483 1,964 1,949 1,845 1,778
227 310 239 240 257 258 271 338 345 405 454 409 466 548 540 564 659 666 551 904 1,042 1,047 850 1,049 1,377 1,358 1,303 1,286
238 207 184 181 194 205 210 190 187 197 186 189 217 226 236 255 302 346 332 403 435 466 343 435 587 591 543 492
3.1 3.9 3.1 5.1 6.0 5.1 11 11 11 14 15 16 18 18 20 21 22 25 25 31 33 35 31 37 39 42 48 51
40 45 42 57 68 71 97 108 99 104 115 144 114 156 119 142 169 207 197 220 238 261 237 267 361 382 314 285
103 117 125 -41 70 91 160 256 150 147 137 164 134 174 137 163 191 232 235 271 294 316 309 303 399 430 365 336
135 90 59 59 105 98 41 -98 32 48 44 21 72 50 98 91 113 156 105 130 134 150 34 132 187 162 178 156
0.0 0.0 0.0 1.5 0.0 0.0 0.0 9.5 12 9.5 6.4 6.0 4.6 3.3 1.8 2.3 3.8 4.0 3.2 8.2 6.9 4.8 1.8 1.5 1.1 2.3
112 75 36 37 74 77 31 -118 32 48 19 18 71 53 95 93 111 152 103 128 132 150 40 134 185 174 41 138
42 33 17 20 23 23 20 4.2 20 18 6.3 12 -3.0 3.7 27 15 27 33 22 66 47 38 11 41 52 35 5.6 22
70 43 18 5.6 52 52 6.2 -124 11 30 13 6.4 74 49 68 78 84 120 81 62 85 112 29 93 133 139 36 117
195 158 139 309 157 139 130 -80 71 89 48 43 90 67 110 115 143 156 144 192 194 206 88 173 226 214 225 187

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?